Pacific Biosciences of California (PACB)
(Real Time Quote from BATS)
$1.86 USD
-0.15 (-7.46%)
Updated Jun 10, 2024 12:42 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | -0.23 |
EPS Last Quarter | -0.26 |
Last EPS Surprise | 0.00% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.90 |
Next Year | -0.74 |
EPS (TTM) | -1.06 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 40.40M | 45.49M | 176.32M | 231.05M |
# of Estimates | 4 | 3 | 4 | 4 |
High Estimate | 41.36M | 48.50M | 184.71M | 262.53M |
Low Estimate | 39.93M | 41.00M | 167.20M | 201.70M |
Year ago Sales | 47.57M | 55.69M | 200.52M | 176.32M |
Year over Year Growth Est. | -15.08% | -18.32% | -12.07% | 31.04% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.23 | -0.22 | -0.90 | -0.74 |
# of Estimates | 3 | 3 | 5 | 4 |
Most Recent Consensus | NA | NA | -0.84 | NA |
High Estimate | -0.21 | -0.19 | -0.84 | -0.62 |
Low Estimate | -0.26 | -0.27 | -1.09 | -0.91 |
Year ago EPS | -0.26 | -0.27 | -1.11 | -0.90 |
Year over Year Growth Est. | 11.54% | 18.52% | 18.92% | 18.56% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 1 |
Up Last 30 Days | 1 | 2 | 4 | 3 |
Up Last 60 Days | 2 | 2 | 4 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 1 | 1 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.23 | -0.22 | -0.90 | -0.74 |
7 Days Ago | -0.23 | -0.22 | -0.91 | -0.75 |
30 Days Ago | -0.24 | -0.24 | -0.98 | -0.82 |
60 Days Ago | -0.25 | -0.25 | -1.01 | -0.85 |
90 Days Ago | -0.25 | -0.25 | -1.01 | -0.85 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.23 | -0.22 | -0.90 | -0.68 |
Zacks Consensus Estimate | -0.23 | -0.22 | -0.90 | -0.74 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 7.94% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.26 | -0.27 | -0.27 | -0.26 | NA |
Estimate | -0.26 | -0.31 | -0.30 | -0.34 | NA |
Difference | 0.00 | 0.04 | 0.03 | 0.08 | 0.04 |
Surprise | 0.00% | 12.90% | 10.00% | 23.53% | 11.61% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more